Investment Thesis
Healthcare Triangle exhibits severe financial distress with persistent operating losses (-$3.6M), negative operating cash flow (-$6.9M), and deteriorating liquidity (current ratio 0.90x). The company is burning cash with minimal runway remaining ($4.3M in cash), unable to generate positive returns or cover interest obligations from operations, indicating elevated default risk.
Strengths
- Moderate leverage with Debt/Equity ratio of 0.16x provides some financial flexibility
- Positive stockholders equity of $52.7M provides a capital cushion above liabilities
- Operating in growing healthcare IT systems integration sector with structural demand
Risks
- Severe liquidity crisis: current ratio of 0.90x indicates inability to cover short-term obligations; negative operating cash flow of -$6.9M indicates rapid cash depletion with estimated 6-12 month runway
- Persistent unprofitability across all levels: operating loss of -$3.6M, net loss of -$6.2M, negative interest coverage of -40.7x indicates inability to service debt from operations
- Deteriorating operational performance: negative gross margin anomaly and sustained losses suggest fundamental business model dysfunction or severe underperformance; no insider purchases in 90 days suggests loss of confidence
Key Metrics to Watch
- Quarterly cash burn rate and remaining cash runway; path to positive operating cash flow
- Revenue growth and operating margin trajectory; achievement of operational breakeven
- Covenant compliance and refinancing risk on $8.5M long-term debt; potential default events
Financial Metrics
Revenue
9.9M
Net Income
-6.2M
EPS (Diluted)
$-6.81
Free Cash Flow
-6.9M
Total Assets
80.2M
Cash
4.3M
Profitability Ratios
Gross Margin
12,531.7%
Operating Margin
-36.8%
Net Margin
-62.9%
ROE
-11.8%
ROA
-7.7%
FCF Margin
-69.9%
Balance Sheet & Liquidity
Current Ratio
0.90x
Quick Ratio
0.90x
Debt/Equity
0.16x
Debt/Assets
34.3%
Interest Coverage
-40.71x
Long-term Debt
8.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-21T07:44:48.713593 |
Data as of: 2026-03-31 |
Powered by Claude AI